← Leaderboards
Craig M Crews
Yale University
$33,790,660
Attributed
$34,173,471
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,173,471 · 15
By mechanism
R01$15,608,226 · 7
R35$9,758,350 · 1
T32$5,957,291 · 1
R21$1,220,117 · 3
R33$879,645 · 1
P30$749,842 · 2
Top collaborators
- Gerd A Blobel1 shared
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeProteinsBaseCellsPharmaceutical PreparationsTechnologyPharmacologic SubstanceInnovationDesignBiologyPathway InteractionsTrainingIn VivoSuccessBiochemicalMolecularTumorProtein DegradationLeadInsightFuturePlayGenesAcademia
Grant awards (95)
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities$976,573
R35 · FY2025 · CA · contact PI
Targeted protein degraders for the treatment of b-hemoglobinopathies$765,622
R01 · FY2025 · HL · contact PI
Yale Center for Molecular Discovery Shared Resource$100,360
P30 · FY2025 · CA · contact PI
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities$915,360
R35 · FY2024 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$87,909
P30 · FY2024 · CA · contact PI
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities$898,724
R35 · FY2023 · CA · contact PI
Developing Tumor-specific PROTACs$374,545
R01 · FY2023 · CA · contact PI
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities$893,050
R35 · FY2022 · CA · contact PI
Developing Tumor-specific PROTACs$374,408
R01 · FY2022 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$104,063
P30 · FY2022 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$877,462
R35 · FY2021 · CA · contact PI
Developing Tumor-specific PROTACs$382,245
R01 · FY2021 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$104,063
P30 · FY2021 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$847,732
R35 · FY2020 · CA · contact PI
Developing Tumor-specific PROTACs$382,271
R01 · FY2020 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$104,063
P30 · FY2020 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$851,137
R35 · FY2019 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$476,613
T32 · FY2019 · GM · contact PI
Developing Tumor-specific PROTACs$382,389
R01 · FY2019 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$104,063
P30 · FY2019 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$11,906
P30 · FY2019 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$877,462
R35 · FY2018 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$471,299
T32 · FY2018 · GM · contact PI
Yale Center for Molecular Discovery Shared Resource$104,063
P30 · FY2018 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$11,906
P30 · FY2018 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$11,905
P30 · FY2018 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$2,858
P30 · FY2018 · CA · contact PI
Yale Center for Molecular Discovery Shared Resource$2,683
P30 · FY2018 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$877,462
R35 · FY2017 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$429,474
T32 · FY2017 · GM · contact PI
KRas Ligand Development$182,156
R21 · FY2017 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$893,462
R35 · FY2016 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$414,955
T32 · FY2016 · GM · contact PI
KRas Ligand Development$217,826
R21 · FY2016 · CA · contact PI
Inducing Protein Degradation: A New Pharmaceutical Paradigm$849,926
R35 · FY2015 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$392,898
T32 · FY2015 · GM · contact PI
Predoctoral Training at the Interface Chemistry and Biology$406,207
T32 · FY2014 · GM · contact PI
Predoctoral Training at the Interface Chemistry and Biology$401,891
T32 · FY2013 · GM · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$381,422
R01 · FY2013 · CA · contact PI
Towards Mammalian Limb Regeneration$318,132
R01 · FY2013 · GM · contact PI
A MULTIPRONGED, PROTEIN DEGRADATION-BASED APPROACH TO INHIBIT HIV TRANSMISSION$459,289
R01 · FY2012 · AI · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$406,626
R01 · FY2012 · CA · contact PI
Towards Mammalian Limb Regeneration$332,247
R01 · FY2012 · GM · contact PI
Predoctoral Training at the Interface Chemistry and Biology$269,277
T32 · FY2012 · GM · contact PI
A MULTIPRONGED, PROTEIN DEGRADATION-BASED APPROACH TO INHIBIT HIV TRANSMISSION$459,415
R01 · FY2011 · AI · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$407,511
R01 · FY2011 · CA · contact PI
Towards Mammalian Limb Regeneration$335,768
R01 · FY2011 · GM · contact PI
Predoctoral Training at the Interface Chemistry and Biology$309,316
T32 · FY2011 · GM · contact PI
Towards Mammalian Limb Regeneration$2,997
R01 · FY2011 · GM · contact PI
A MULTIPRONGED, PROTEIN DEGRADATION-BASED APPROACH TO INHIBIT HIV TRANSMISSION$461,265
R01 · FY2010 · AI · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$460,628
R01 · FY2010 · CA · contact PI
Towards Mammalian Limb Regeneration$315,213
R01 · FY2010 · GM · contact PI
Predoctoral Training at the Interface Chemistry and Biology$306,141
T32 · FY2010 · GM · contact PI
Analysis of Tumorigenic Signaling Pathways with PROTACS$299,483
R33 · FY2010 · CA · contact PI
A MULTIPRONGED, PROTEIN DEGRADATION-BASED APPROACH TO INHIBIT HIV TRANSMISSION$466,786
R01 · FY2009 · AI · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$413,750
R01 · FY2009 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$304,599
T32 · FY2009 · GM · contact PI
Analysis of Tumorigenic Signaling Pathways with PROTACS$294,351
R33 · FY2009 · CA · contact PI
Predoctoral Training at the Interface Chemistry and Biology$87,028
T32 · FY2009 · GM · contact PI
Anti-inflammatory Natural Product Mode of Action Studies$379,503
R01 · FY2008 · AI · contact PI
Predoctoral Training at the Interface Chemistry and Biology$303,056
T32 · FY2008 · GM · contact PI
Natural Product Model of Action Studies$294,002
R01 · FY2008 · GM · contact PI
Analysis of Tumorigenic Signaling Pathways with PROTACS$285,811
R33 · FY2008 · CA · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$33,100
R01 · FY2008 · CA · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$458,286
R01 · FY2007 · CA · contact PI
Anti-inflammatory Natural Product Mode of Action Studies$386,874
R01 · FY2007 · AI · contact PI
Natural Product Model of Action Studies$287,288
R01 · FY2007 · GM · contact PI
Predoc Training at the Interface Chemistry and Biology$284,078
T32 · FY2007 · GM · contact PI
Predoc Training at the Interface Chemistry and Biology$42,406
T32 · FY2007 · GM · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$458,227
R01 · FY2006 · CA · contact PI
Anti-inflammatory Natural Product Mode of Action Studies$398,450
R01 · FY2006 · AI · contact PI
Predoc Training at the Interface Chemistry and Biology$296,840
T32 · FY2006 · GM · contact PI
Natural Product Model of Action Studies$289,558
R01 · FY2006 · GM · contact PI
Analysis of Tumorigenic Signaling Pathways with PROTACS$194,867
R21 · FY2006 · CA · contact PI
Role of MetAP-2 in Angiogenesis and Wnt Signaling$455,588
R01 · FY2005 · CA
Anti-inflammatory Natural Product Mode of Action Studies$399,532
R01 · FY2005 · AI
Predoc Training at the Interface Chemistry and Biology$296,840
T32 · FY2005 · GM
Natural Product Model of Action Studies$208,379
R01 · FY2005 · GM
NATURAL PRODUCT MODE OF ACTION STUDIES$89,925
R01 · FY2005 · GM
MetAP-2 in Angiogenesis and Wnt Signaling$403,078
R01 · FY2004 · CA
Anti-inflammatory Natural Product Mode of Action Studies$381,203
R01 · FY2004 · AI
Predoc Training at the Interface Chemistry and Biology$254,435
T32 · FY2004 · GM
METAP2 KNOCKOUT MICE--ANGIOSTATIC DRUG TARGET VALIDATION$65,400
R01 · FY2004 · CA
Predoc Training at the Interface Chemistry and Biology$43,788
T32 · FY2004 · GM
METAP2 KNOCKOUT MICE--ANGIOSTATIC DRUG TARGET VALIDATION$408,956
R01 · FY2003 · CA
Pancreatic Stem Cell Induction by Small Molecules$286,125
R21 · FY2003 · DK
NATURAL PRODUCT MODE OF ACTION STUDIES$269,275
R01 · FY2003 · GM
Predoc Training at the Interface Chemistry and Biology$166,150
T32 · FY2003 · GM
METAP2 KNOCKOUT MICE--ANGIOSTATIC DRUG TARGET VALIDATION$395,550
R01 · FY2002 · CA
Pancreatic Stem Cell Induction by Small Molecules$339,143
R21 · FY2002 · DK
NATURAL PRODUCT MODE OF ACTION STUDIES$269,289
R01 · FY2002 · GM
METAP2 KNOCKOUT MICE--ANGIOSTATIC DRUG TARGET VALIDATION$382,575
R01 · FY2001 · CA
NATURAL PRODUCT MODE OF ACTION STUDIES$375,749
R01 · FY2001 · GM
METAP2 KNOCKOUT MICE--ANGIOSTATIC DRUG TARGET VALIDATION$377,001
R01 · FY2000 · CA
NATURAL PRODUCT MODE OF ACTION STUDIES$258,909
R01 · FY2000 · GM